ICD-10-CM Billable Code

R78.71

Abnormal lead level in blood

Clinical Classification Guidelines

Excludes Type 1

  • lead poisoning (T56.0-)

Medical Intelligence & Overview

An abnormal lead level in blood, classified under ICD-10 code R78.71, indicates the presence of an unusual amount of lead in the bloodstream. Lead is a heavy metal that can be toxic to the body, especially when levels are elevated. Monitoring and managing lead levels are crucial because excess lead can cause serious health issues, affecting various organs and systems. This condition can arise from exposure to lead-containing materials or environments, making awareness and early detection vital for health and safety.

Causes & Symptoms

Clinical Causes: Exposure to lead-based paints, especially in older buildings Contaminated soil or dust containing lead particles Use of contaminated water via lead pipes or fixtures Workplace exposure, such as in construction, mining, or manufacturing industries Ingestion of foods or products containing lead, like certain imported candies or ceramic glazes Recreational activities that disturb lead-containing materials

Key Symptoms: Fatigue and weakness Abdominal pain and nausea Learning difficulties or behavioral issues in children Memory problems Muscle or joint pain Headaches Anemia or pallor Potential kidney damage in severe cases Neurological symptoms, such as tingling or numbness

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves blood tests to measure the concentration of lead in the bloodstream. The laboratory results help determine whether the lead level exceeds normal limits and guide medical management. In some cases, additional tests, such as X-rays or urine analysis, may be used to assess lead exposure and distribution within the body. Healthcare providers also review a patient's history of possible lead exposure sources to support diagnosis and treatment planning.

Treatment Protocols: Treatment strategies focus on reducing lead levels and preventing further exposure. Approaches include chelation therapy, which involves medications that bind to lead and help remove it from the body, especially in cases of significant poisoning. Supportive care may include nutritional interventions to improve overall health. Removing or avoiding sources of lead exposure is essential for recovery and preventing recurrence. In children, close monitoring and supportive therapies are crucial due to the potential impact on development. Long-term follow-up may be necessary to assess health outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R78.71 a billable ICD-10 code?
Yes, R78.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R78.71?
Clinical documentation must specify the nature of Abnormal lead level in blood and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

abnormal blood level